Y-mAbs Therapeutics, Inc (NASDAQ:YMAB)

32.97
Delayed Data
As of Jan 17
 +0.35 / +1.07%
Today’s Change
18.60
Today|||52-Week Range
34.49
+5.50%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Y-mAbs Therapeutics, Inc have a median target of 39.00, with a high estimate of 41.00 and a low estimate of 35.00. The median estimate represents a +18.29% increase from the last price of 32.97.

Analyst Recommendations

The current consensus among 8 polled investment analysts is to Buy stock in Y-mAbs Therapeutics, Inc. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.66
Sales
$0.00
Reporting Date
Mar 20

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.31%
 
 
 
 
 
 
Growthannually -52.89%
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
Key to the earnings and sales forecast charts.